Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HY-2003 for Submental Fat Accumulation
NCT06756490Phase 1Recruiting
- Sponsor
- Sichuan Huiyu Pharmaceuticals
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of HY-2003 in submental fullness (3 arms), sponsored by Sichuan Huiyu Pharmaceuticals. Primary endpoints: Occurrence of all adverse events, Visual Analogue Scale and 1 more. Started Dec 2024; status: recruiting.
02
Drugs
HY-2003
03
Conditions
submental fullness
Beyond the preview
Go deeper on NCT06756490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756490.